Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

IDEAYA brings in $46mm through Series A round

Executive Summary

Oncology drug discovery start-up IDEAYA Biosciences Inc. raised $46mm through its Series A round. Seed investor 5AM Ventures participated, along with Canaan Partners, Celgene, WuXi Healthcare Ventures, Novartis Institutes for BioMedical Research, and Alexandria Real Estate. Canaan joined the company's board of directors and Celgene and WuXi joined as board advisors.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies